NEW!

More documents

Recommendations

Info

Saturday, April 16 Integrated Neuroscience Session I2 1:00 p.m.–5:30 p.m. Integrated Neuroscience Session Stroke in the Elderly and Young: Challenges for the Next Decade Coordinators: Seemant Chaturvedi, MD, FAAN, FAHA, and Cheryl Bushnell, MD, MHS Program Description: At the two ends of the age spectrum, rates of stroke are rising. Both young patients and the elderly have unique stroke presentations and unique challenges in management. Both groups can have substantial rates of misdiagnosis and under treatment. Faculty will review the unique challenges of stroke in children and young adults, as well as in the elderly. Data will be reviewed pertaining to treatment modalities that are both underutilized and over utilized in these populations. Upon Completion: Participants should be able to identify the common presentations and most common etiologies for stroke in young adults. Participants should also understand the public health impact of stroke in young adults. Attendees will also appreciate the risks of under treatment and overtreatment of stroke in the elderly. Part I 1:00 p.m.–3:00 p.m. 1:00 p.m.–1:10 p.m. Introduction Seemant Chaturvedi, MD, FAAN, FAHA, and Cheryl Bushnell, MD, MHS 1:10 p.m.–1:45 p.m. Invited Speaker Novel Insights into the Pathogenesis of Stroke in Children Catherine Amlie-Lefond, Seattle, WA 1:45 p.m.–1:50 p.m. I2.001 Data Blitz Current Practices and Variability in Feeding Tube Placement for Inpatients with Intracerebral Hemorrhage in US Hospitals —David Hwang, Benjamin George, Adam Kelly, Eric Schneider, Kevin Sheth, Robert Holloway 1:50 p.m.–1:55 p.m. I2.002 Data Blitz Neuroimaging Markers of Cognitive Outcome in Children with Perinatal Stroke — Kara Murias, Adam Kirton, Sana Tariq, Andrea Moir, Giuseppe Iaria 1:55 p.m.–2:05 p.m. Audience Q&A 2:05 p.m.–2:40 p.m. Invited Speaker Are Stroke Rates Really Rising in Young Adults and What Can Be Done About It? Cheryl Bushnell, MD, MHS, Winston Salem, NC 2:40 p.m.–2:45 p.m. I2.003 Data Blitz Temporal Trends in Stroke Incidence in the Young in the Framingham Study —Hugo Javier Aparicio, Alexa Beiser, Jayandra Himali, Claudia Satizabal, Matthew Pase, Jose Romero, Carlos Kase, Sudha Seshadri 2:45 p.m.–2:50 p.m. I2.004 Data Blitz Infections Present on Admission and Stroke in the Young —Amelia Boehme, Rebecca Hazan, Eliza Miller, Shadi Yaghi, Sara Rostanski, Joshua Willey, Randolph Marshall, Mitchell Elkind 2:50 p.m.–3:00 p.m. Audience Q&A Guided Poster Rounds I2.001 Current Practices and Variability in Feeding Tube Placement for Inpatients with Intracerebral Hemorrhage in US Hospitals —David Hwang, Benjamin George, Adam Kelly, Eric Schneider, Kevin Sheth, Robert Holloway I2.002 Neuroimaging Markers of Cognitive Outcome in Children with Perinatal Stroke —Kara Murias, Adam Kirton, Sana Tariq, Andrea Moir, Giuseppe Iaria I2.003 Temporal Trends in Stroke Incidence in the Young in the Framingham Study —Hugo Javier Aparicio, Alexa Beiser, Jayandra Himali, Claudia Satizabal, Matthew Pase, Jose Romero, Carlos Kase, Sudha Seshadri I2.004 Infections Present on Admission and Stroke in the Young — Amelia Boehme, Rebecca Hazan, Eliza Miller, Shadi Yaghi, Sara Rostanski, Joshua Willey, Randolph Marshall, Mitchell Elkind 3:00 p.m.–3:30 p.m. I2.005 Incidence of Atrial Fibrillation Within One Year of Cryptogenic Stroke Among a Large, Real-World Population with Insertable Cardiac Monitors —John Rogers, Allan Nichols, Mark Richards, Scott Ferreira, Shantanu Sarkar, Jodi Koehler, Eduardo Warman, Paul Ziegler I2.006 African Americans Are Less Likely to Be Adherent to Statins After Ischemic Stroke: An Analysis of Medicare Beneficiaries Following Hospital Discharge —Karen Albright, Justin Blackburn, Hong Zhao, T. Beasley, Nita Limdi, Virginia Howard, Paul Muntner I2.007 Rate of Endovascular Therapy in Octogenarian/Nonagenarian Acute Ischemic Stroke Patients Compared to Younger Patients —Fadar Otite, Priyank Khandelwal, Anita Tipirneni, Melissa Fellman, Amer Malik, Dileep Yavagal, Seemant Chaturvedi I2.008 Endovascular Treatment for Acute Ischemic Stroke in Nonagenarians Compared with Younger Patients in a Multicenter Cohort —David Miller, Muhib Khan, Shawn Tsekhan, Grayson Baird, Nils Henninger, Anand Patel, Ajit Puri, Shadi Yaghi, Mahesh Jayaraman, Brian Silver I2.009 Significance of BNP for Neurological Severity in Acute Ischemic Stroke —Takahiro Kuwashiro, Masahiro Yasaka, Yuriko Ito, Keisuke Tokunaga, Go Takaguchi, Asako Nakamura, Seiji Gotoh, Yasushi Okada I2.010 Antithrombotic Strategy in Cerebral Venous Thrombosis: Differences Between Neurologists and Haematologists in a Canadian Survey — Sohaila Alshimemeri, Marie-Christine Camden, Gary Lui, Agnes Lee, Thalia Field Part II I2.011 Worsening Severity of Migraines in Current Users of Hormone Replacement Therapy Correlates to Increased Risk of Ischemic Stroke — Haseeb Rahman, Abraham Thomas, Ahmed Malik, Omar Saeed, Adnan Qureshi I2.012 Argentinean Initiative of Stroke in the Young and Fabry Disease (FD): Final Results —Ricardo Reisin, Julieta Mazziotti, Luciana Leon Cejas, Alberto Zinnerman, Pablo Bonardo, Manuel Fernandez Pardal, Alejandra Martinez, Luciano Alberto Sposato, Sebastian Ameriso, Eduardo Bendersky, Pedro Nofal, Patricia Cairola, Lorena Jure, Andrea Sotelo, Paula Rozenfeld, Romina Ceci, Ignacio Casas- Parera, Analia Sanchez Luceros I2.013 Exploring Protein Quantitation Methods to Detect Useful Plasma Biomarkers for Distinguishing Ischemic Stroke from Mimic —Andrew Penn, Robert Balshaw, Mary Lesperance, Viera Saly, Angela Jackson, Derek Smith, Kristine Votova, Linghong Lu, Jaclyn Morrison, Shelagh Coutts, Christoph Borchers 3:30 p.m.–5:30 p.m. 3:30 p.m.–4:05 p.m. Invited Speaker Stroke Prevention in the Elderly: What Works, What Does Not Work? Seemant Chaturvedi, MD, FAAN, FAHA, Miami, FL 4:05 p.m.–4:10 p.m. I2.005 Data Blitz Incidence of Atrial Fibrillation Within One Year of Cryptogenic Stroke Among a Large, Real-World Population with Insertable Cardiac Monitors —John Rogers, Allan Nichols, Mark Richards, Scott Ferreira, Shantanu Sarkar, Jodi Koehler, Eduardo Warman, Paul Ziegler 4:10 p.m.–4:15 p.m. I2.006 Data Blitz African Americans Are Less Likely to Be Adherent to Statins After Ischemic Stroke: An Analysis of Medicare Beneficiaries Following Hospital Discharge —Karen Albright, Justin Blackburn, Hong Zhao, T. Beasley, Nita Limdi, Virginia Howard, Paul Muntner 4:15 p.m.–4:25 p.m. Audience Q&A 4:25 p.m.–5:00 p.m. Invited Speaker Acute Stroke Therapy in the Elderly: Which Treatments are Safe and Effective? Andrew M. Demchuk, MD, Calgary, Canada 5:00 p.m.–5:05 p.m. I2.007 Data Blitz Rate of Endovascular Therapy in Octogenarian/Nonagenarian Acute Ischemic Stroke Patients Compared to Younger Patients —Fadar Otite, Priyank Khandelwal, Anita Tipirneni, Melissa Fellman, Amer Malik, Dileep Yavagal, Seemant Chaturvedi 5:05 p.m.–5:10 p.m. I2.008 Data Blitz Endovascular Treatment for Acute Ischemic Stroke in Nonagenarians Compared with Younger Patients in a Multicenter Cohort —David Miller, Muhib Khan, Shawn Tsekhan, Grayson Baird, Nils Henninger, Anand Patel, Ajit Puri, Shadi Yaghi, Mahesh Jayaraman, Brian Silver 5:10 p.m.–5:20 p.m. Audience Q&A 5:20 p.m.–5:30 p.m. Conclusion 40 2016 AAN Annual Meeting Abstract Listing
$ A registration fee is required L The program is one of the AAN Leadership University sessions S The course is part of a Subspecialty in Focus track I The program is one of the I Talk sessions Learning Lab Excitement of Discovery Health & Wellness Real World of Neurology The program is part of the Experiential Learning Area sessions Meeting Schedule 3:30 p.m.–4:15 p.m. Scientific Platform Session S6: Global Health 3:30 p.m. S6.001 Stigma Reduction Efforts: Evaluating a Multi-Faceted Intervention Aimed at Teachers in Zambia —Masharip Atadzhanov, Natalie Thornton, Elwyn Chomba, Edward Mbewe, Gretchen Birbeck 3:45 p.m. S6.002 Prediction of Incident Epilepsy After First Seizure in Children with HIV/AIDS in Botswana —David Bearden, Dennis Dlugos 4:00 p.m. S6.003 Medication Versus Management: Beyond Pills-to-Mouths Measures of Epilepsy Care —Erica McKenzie, Damber Nirola, Lhab Tshering, Sonam Deki, Bryan Patenaude, Sarah Clark, Sydney Cash, Ronald Thibert, Rodrigo Zepeda Garcia, Edward Leung, Alice Lam, Andrew Lim, Jo Mantia, Joseph Cohen, Andrew Cole, Farrah Mateen 3:30 p.m.–5:30 p.m. Scientific Platform Session S7: Stroke Clinical Trials 3:30 p.m. S7.001 Muscle Selection Patterns for Injection of OnabotulinumtoxinA in Adult Patients with Post-Stroke Lower-Limb Spasticity Influence Outcome: Results from a Double-Blind, Placebo-Controlled Phase 3 Clinical Trial —Theodore Wein, Alberto Esquenazi, Anthony Ward, Carolyn Geis, Chengcheng Liu, Rozalina Dimitrova 3:45 p.m. S7.002 Sustained Benefit with Repeated Treatments of OnabotulinumtoxinA in Post-Stroke Lower Limb Spasticity: 1-Year Open-Label Final Results from a Double-Blind, Placebo-Controlled, Phase 3 Trial —Theodore Wein, Carolyn Geis, Ziyad Ayyoub, Stanislaw Ochudlo, Lynn James, Grace Pan, Andrzej Bogucki, Rozalina Dimitrova 4:00 p.m. S7.003 Non-Invasive Therapy of Symptomatic High Grade Carotid Stenosis Using [Tin-117m]-DOTA-Annexin V —Gilbert Gonzales, Harry Strauss, Suresh Srivastava, Nigel Steverson 4:15 p.m. S7.004 GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia —Kevin Sheth, Jordan Elm, Holly Hinson, Bradley Molyneaux, Lauren Beslow, Gordon Sze, Ann-Christin Ostwaldt, Gregory Del Zoppo, J Simard, Sven Jacobson, W. Kimberly 4:30 p.m. S7.005 Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke (AIS): Results from ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial — Jacob Elkins, Mitchell Elkind, Roland Veltkamp, Joan Montaner, S Johnston, Aneesh Singhal, Kyra Becker, Maarten Lansberg, Ih Chang, Weihua Tang, Sarah Gheuens, Lahar Mehta 4:45 p.m. S7.006 GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis As Proof-Of-Concept —W. Taylor Kimberly, Jordan Elm, Holly Hinson, Bradley Molyneaux, Lauren Beslow, Gordon Sze, Ann-Christin Ostwaldt, Gregory Del Zoppo, Marc Simard, Kevin Sheth 5:00 p.m. S7.007 Clinical Impairment in Patients Followed with or Without Interventional Therapy in a Randomized Trial of Unruptured Brain AVMs (ARUBA)—J. Mohr, Jessica Overbey, Christian Stapf, Andreas Hartmann, Marco Stefani, Michael Parides, Ellen Moquete, Claudia Moy, E Vicaut, Alan Moskowitz, R. Al-Shahi Salman, E. Houdart, Charlotte Cordonnier, Ruediger von Kummer, Alessandra Biondi, J. Berkefeld, C. Klijn, Kristy Harkness, Richard Libman, X Barreau, Helen Kim 5:15 p.m. S7.008 A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair —Steven Messe, Laura Demopoulos, Thomas Haws, Ali Khonezhad, Bradley Leshnower, Joseph Coselli, Jehangir Appoo, G Hughes, T Reece, Derek Brinster, Scott Kasner, John Kern, Nimesh Desai, Victoria Ballard, Frank Fang, John Lepore, Joseph Bavaria 4:30 p.m.–5:30 p.m. Scientific Platform Session S8: Practice and Policy 4:30 p.m. S8.001 The Impact of Professional Medical Interpreter Involvement on the Care of Acute Ischemic Stroke Patients at an Academic Medical Center —Betty Luan Erfe, Khawja Siddiqui, Lee Schwamm, Nicte Mejia 4:45 p.m. S8.002 Getting the Point: Changing to the Atraumatic Needle at Walter Reed National Military Medical Center — Michael Johnson 5:00 p.m. S8.003 Examination of the Effects of Chronic Exposure to Federally-Regulated and Approved Levels of Methyl Bromide in Dock Workers: A Case Series —Joseph McCall, David Harris, Matthew Berk 5:15 p.m. S8.004 A Quality Improvement Project to Improve Trainee Compliancewith the AAN Guidelines for Neurological Prognosis After Cardiac Arrest — Proleta Datta, Jennifer Padilla Martinez, Omotola Hope, Huimahn Choi 4:30 p.m.–5:30 p.m. S8 Practice and Policy 5:30 p.m.–6:30 p.m. I Neurology Compensation and Productivity Survey and Dashboard Report Directors: David A. Evans, MBA, Dallas, TX, Bryan Soronson, CRA, FACMPE, MPA, Baltimore, MD Sat · April 16 6:00 p.m.–9:00 p.m. Faculty and Trainee Reception 6:30 p.m.–9:30 p.m. C51 Case Studies in Behavioral Neurology: Focus on Frontotemporal Degeneration Director: Daniel Kaufer, MD, FAAN, Chapel Hill, NC C52 Case Studies: Challenging Headache Cases Director: Kathleen B. Digre, MD, FAAN, Salt Lake City, UT C53 Case Studies: Unusual Movement Disorders Director: Anthony E. Lang, MD, FAAN, Toronto, ON C54 Case Studies: Multiple Sclerosis Director: John Corboy, MD, FAAN, Aurora, CO C55 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease Director: Anne M. Connolly, MD, St. Louis, MO C56 Test Your Knowledge: A Case-based Approach to Neuroimaging Director: Joseph C. Masdeu, MD, PhD, FAAN, Houston, TX C57 Case Studies: How to Analyze Spells by Video-EEG Director: Joseph F. Drazkowski, MD, FAAN, Phoenix, AZ C58 Case Studies in the ICU Director: Nicholas Joseph Silvestri, MD, Buffalo, NY Fast and easy registration · AAN.com/view/AM16 41
Page 1 and 2: NEW! Dates • Format • Value SCI
Page 3 and 4: See the value! 2015 Meeting Price 2
Page 5 and 6: What’s Inside Table of Contents I
Page 7 and 8: Meeting! INTRODUCTION See You in Va
Page 9 and 10: Additional Information INTRODUCTION
Page 11 and 12: OVERVIEWS Mon April 18 Tue April 19
Page 13 and 14: Schedule Planning Forms Use the con
Page 15 and 16: My Friday $ A registration fee is r
Page 17 and 18: Hot Topics Plenary Session Friday,
Page 19 and 20: $ A registration fee is required L
Page 21 and 22: Meeting Schedule 6:30 a.m.-8:30 a.m
Page 23 and 24: Poster Session Schedule and Floorpl
Page 25 and 26: Meeting Schedule P1.029 Efficacy an
Page 27 and 28: Presenters Stand by Posters 5:30 p.
Page 35 and 36: New Faculty and Trainee Reception!
Page 37 and 38: Meeting Schedule 11:30 a.m.-6:30 p.
Page 39 and 40: Saturday, April 16 1:00 p.m.-3:00 p
Page 41: Meeting Schedule 1:00 p.m.-5:30 p.m
Page 47 and 48: Meeting Schedule 6:30 a.m.-7:15 a.m
Page 59 and 60: Sunday, April 17 Scientific Platfor
Page 61 and 62: Meeting Schedule 1:00 p.m.-5:00 p.m
Page 63 and 64: I5 1:00 p.m.-5:30 p.m. Integrated N
Page 65 and 66: Opening Party Experience New Ways t
Page 69 and 70: Don’t Forget to Visit the Exhibit
Page 79 and 80: P3.391 The Quix Test: A 30 Second T
Page 81 and 82: Annual Meeting App Now Available Th
Page 83 and 84: Meeting Schedule 9:00 a.m.-11:30 a.
Page 85 and 86: Meeting Schedule 1:00 p.m.-5:30 p.m
Page 87 and 88: I8 1:00 p.m.-5:30 p.m. Integrated N
Page 89 and 90: Industry Therapeutic Updates Indust
Page 93 and 94:
Meeting Schedule 6:30 a.m.-8:30 a.m
Page 95 and 96:
Presenters Stand by Posters 5:30 p.
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Frontiers in Neuroscience Plenary S
Page 105 and 106:
Meeting Schedule 1:00 p.m.-3:00 p.m
Page 107 and 108:
Page 109 and 110:
$ A registration fee is required L
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Clinical Trials Plenary Session Wed
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Scientific Platform Sessions Meetin
Page 133 and 134:
My Thursday $ A registration fee is
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Neurology Year in Review Plenary Se
Page 147 and 148:
Page 149 and 150:
1:00 p.m.-5:30 p.m. Integrated Neur
Page 151 and 152:
New Date and Time: CLOSING PARTY HA
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Association of Indian Neurologists
Page 161 and 162:
Potamkin Prize for Research in Pick
Page 163 and 164:
Cool An AAN initiative to help buil
Page 165 and 166:
Closing Party Happy Hour Thursday,
Page 167 and 168:
Annual Meeting Attendee Pricing: Go
Page 169 and 170:
Disclaimers/Disclosures Disclaimer
Page 171 and 172:
Hotel Reservations Why Book a Hotel
Page 173 and 174:
Sitka Sq Abbott St Ontario St Ontar
Page 175 and 176:
Luggage Restrictions for carry-on b
Page 177 and 178:
68 th Annual Meeting Exhibitors as
Page 179 and 180:
68 th Annual Meeting Planning Meeti
Page 181 and 182:
Jonathan S. Katz, MD Jori Fleisher,
Page 183 and 184:
AAN Leadership University courses a
show all

NEW!

Create successful ePaper yourself

Delete template?

Save as template?